Balyasny Asset Management LLC Pacira Bio Sciences, Inc. Transaction History

Balyasny Asset Management LLC

$61.9 Billion
Q2 2025

A detailed history of Balyasny Asset Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 2,130,733 shares of PCRX stock, worth $49 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,130,733

Previous 1,565,445 36.11%

Holding current value

$49 Million

Previous $38.9 Million 30.91%

% of portfolio

0.08%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$22.91 - $27.14 $13 Million - $15.3 Million	565,288 Added 36.11%	2,130,733 $50.9 Million
Q1 2025 May 15, 2025	BUY	$18.33 - $27.25 $20.7 Million - $30.8 Million	1,131,239 Added 260.53%	1,565,445 $38.9 Million
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $6.64 Million - $8.83 Million	434,206 New	434,206 $8.18 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $22.2 Million - $29.2 Million	615,047 Added 2071.49%	644,738 $25.8 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $1.05 Million - $1.29 Million	29,691 New	29,691 $1.21 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $6.73 Million - $8.49 Million	-188,752 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $6.9 Million - $9.05 Million	188,752 New	188,752 $8.21 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $1.53 Million - $1.77 Million	-41,978 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $58,618 - $74,015	1,419 Added 3.5%	41,978 $1.81 Million
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $471,660 - $746,616	-14,358 Reduced 26.14%	40,559 $1.99 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $11.2 Million - $16.2 Million	-406,185 Reduced 88.09%	54,917 $1.76 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $2.5 Million - $3.87 Million	83,389 Added 22.08%	461,102 $14.4 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $9.96 Million - $14.7 Million	312,813 Added 481.99%	377,713 $17.2 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $2.32 Million - $2.56 Million	64,900	64,900 $2.44 Million

Others Institutions Holding PCRX

# of Institutions

259

Shares Held

51M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.05B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Pacira Bio Sciences, Inc. Transaction History